Percutaneous treatment of coronary artery disease
DOI:
https://doi.org/10.6016/ZdravVestn.3246Keywords:
percutaneous coronary intervention, stent, balloon angioplasty, coronary disease, historyAbstract
There is no abstract for this article.
Downloads
References
1. Žlahtič T, Vitez L, Bunc M. Preteklost, sedanjost, prihodnost: razvoj perkutane koronarne intervencije. Zdrav Vestn. 2021;90():.
2. European Cardiovascular Disease statistics 2017. Brussels: European Heart Network; 2017. Available from: https://ehnheart.org/cvd-statistics/cvd-statistics-2017.html.
3. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al.; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407-77.
DOI: 10.1093/eurheartj/ehz425
PMID: 31504439
4. Montalescot G, Dallongeville J, Van Belle E, Rouanet S, Baulac C, Degrandsart A, et al.; OPERA Investigators. STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry). Eur Heart J. 2007;28(12):1409-17.
DOI: 10.1093/eurheartj/ehm031
PMID: 17412730
5. Simoons ML, Windecker S. Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization. Eur Heart J. 2010;31(5):530-41.
DOI: 10.1093/eurheartj/ehp605
PMID: 20106842
6. Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al.; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503-16.
DOI: 10.1056/NEJMoa070829
PMID: 17387127
7. Al-Lamee R, Thompson D, Dehbi HM, Sen S, Tang K, Davies J, et al.; ORBITA investigators. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. 2018;391(10115):31-40.
DOI: 10.1016/S0140-6736(17)32714-9
PMID: 29103656
8. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al.; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-77.
DOI: 10.1093/eurheartj/ehx393
PMID: 28886621
9. Collet JP, Thiele H, Barbato E, Barthelemy O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal. 2020;00:1-79.
DOI: 10.1093/eurheartj/ehaa575
PMID: 32860058
10. Waller BF, Orr CM, Pinkerton CA, VanTassel JW, Pinto RP. Morphologic observations late after coronary balloon angioplasty: mechanisms of acute injury and relationship to restenosis. Radiology. 1990;174(3 Pt 2):961-7.
DOI: 10.1148/radiology.174.3.174-3-961
PMID: 2406792
11. Hong MK. Restenosis following coronary angioplasty: current status. Korean J Intern Med (Korean Assoc Intern Med). 2001;16(2):51-5.
DOI: 10.3904/kjim.2001.16.2.51
PMID: 11590901
12. James SK, Stenestrand U, Lindbäck J, Carlsson J, Scherstén F, Nilsson T, et al.; SCAAR Study Group. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. N Engl J Med. 2009;360(19):1933-45.
DOI: 10.1056/NEJMoa0809902
PMID: 19420363
13. Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation. 2007;115(11):1440-55.
DOI: 10.1161/CIRCULATIONAHA.106.666800
PMID: 17344324
14. Palmerini T, Benedetto U, Biondi-Zoccai G, Della Riva D, Bacchi-Reggiani L, Smits PC, et al. Long-term safety of drug-eluting and bare-metal stents. J Am Coll Cardiol. 2015;65(23):2496-507.
DOI: 10.1016/j.jacc.2015.04.017
PMID: 26065988
15. Tomberli B, Mattesini A, Baldereschi GI, Di Mario C. A Brief History of Coronary Artery Stents. Rev Esp Cardiol (Engl Ed). 2018;71(5):312-9.
DOI: 10.1016/j.rec.2017.11.022
PMID: 29361499
16. Stone GW, Ellis SG, Gori T, Metzger DC, Stein B, Erickson M, et al.; ABSORB IV Investigators. Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial. Lancet. 2018;392(10157):1530-40.
DOI: 10.1016/S0140-6736(18)32283-9
PMID: 30266412
Downloads
Published
Issue
Section
License
The Author transfers to the Publisher (Slovenian Medical Association) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Slovenian Medical Association) has the right to transfer the rights of acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
